Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: November 24, 2025
Principal Executive Office: Level 14, 350 Collins Street, Melbourne, Victoria 3000 Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural filing regarding director interests and does not contain financial statements.
Material Changes
No material financial changes versus a prior comparable period are disclosed in this document.
Guidance, Outlook, and Risks
Management Commentary: None provided in this filing.
Exhibits: The filing includes Exhibit 99.1, a "Final Director's Interest Notice - Kempler."
Registration Statements: This Form 6-K is incorporated by reference into Registration Statements on Form S-8 (Files No. 333-251073, 333-248980, 333-228671) and Form F-3 (Files No. 333-274816, 333-251647, 333-231417, 333-250076).
Investor Verification Checklist
- Verify the specific details of the Director's Interest Notice for "Kempler" referenced in Exhibit 99.1.
- Confirm the status of the referenced Form S-8 and Form F-3 registration statements.
- Note that this filing contains no financial performance data; refer to the most recent Form 20-F for financial metrics.